APBI using multi-catheter brachytherapy is currently the only method of breast irradiation with a treatment duration of merely 4–5 days with level 1 evidence showing it to be a valid treatment alternative to WBI after breast conserving surgery (BCS) for low-risk breast cancer patients used in clinical routine.1
Studies continue into the use of brachytherapy to further reduce the number of fractions treated for APBI.2
We invite you to a presentation with Dr. Yaw Chin, Radiation Oncologist at The St George Cancer Care Centre at St George Hospital in Australia. Dr Chin will discuss a prospective, single arm, phase II non-inferiority clinical trial to investigate:
- if a three dose schedule of partial breast radiation using multi-catheter interstitial brachytherapy is feasible and comparable to a ten dose schedule in terms of the risk of tumor returning in the same breast.
- potential treatment-related side effects.
- cosmetic outcomes.3
Don't miss this opportunity to learn more about the 3 fraction APBI brachytherapy.
1 Strnad et al., (V. Strnad). Radiotherapy and Oncology 128 (2018) 411–420
2 Khan et al, Int J Radiation Oncol Biol Phys, Vol. 104, No. 1, pp. 67e74, 2019
3 HEARTBEAT Study, St. George Hospital/Sydney, December 2020
For this webinar, we will be using the platform MS Teams. For information on how they handle your data, please visit https://docs.microsoft.com/en-us/MicrosoftTeams/teams-privacy. This webinar will be recorded and registered attendees will receive a copy of the recording after the webinar has taken place. For information on how Elekta handles your data, please visit https://www.elekta.com/privacy/
Please note times are in Hong Kong Time (HKT).